A genome-wide survey for prion-regulated miRNAs associated with cholesterol homeostasis

BMC Genomics

Volumn 13, Issue 1, 2012, Pages

  Montag, Judith ^a   Brameier, Markus ^a   Schmädicke, Ann Christin ^a   Gilch, Sabine ^b,c   Schätzl, Hermann M ^b,c   Motzkus, Dirk ^a  

^a GERMAN PRIMATE CENTER   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF WYOMING   (United States)

Author keywords

Cholesterol; Joint profiling; MicroRNA; Prion disease; Ultra deep sequencing

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; MICRORNA; PRION PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 2;

ANIMAL CELL; ARTICLE; CHOLESTEROL METABOLISM; CONTROLLED STUDY; DOWN REGULATION; GENE CLUSTER; GENE IDENTIFICATION; GENE SEQUENCE; HIGH THROUGHPUT SEQUENCING; MOUSE; NONHUMAN; PRION DISEASE; PROTEIN DEGRADATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA SEQUENCE; UPREGULATION; X CHROMOSOME;

ANIMALS; CELL LINE; CHOLESTEROL; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HOMEOSTASIS; MICE; MICRORNAS; PRIONS; PROTEIN ISOFORMS;

EID: 84866168906     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-13-486     Document Type: Article

References (61)

1. Chesebro B. Introduction to the transmissible spongiform encephalopathies or prion diseases. Br Med Bull 2003, 66:1-20. 10.1093/bmb/66.1.1, 14522845.
2. Prusiner SB. Molecular biology of prion diseases. Science (New York, NY) 1991, 252(5012):1515-1522.
3. Pan KM, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D, Mehlhorn I, Huang Z, Fletterick RJ, Cohen FE, et al. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A 1993, 90(23):10962-10966. 10.1073/pnas.90.23.10962, 47901, 7902575.
4. Schatzl HM, Laszlo L, Holtzman DM, Tatzelt J, DeArmond SJ, Weiner RI, Mobley WC, Prusiner SB. A hypothalamic neuronal cell line persistently infected with scrapie prions exhibits apoptosis. J Virol 1997, 71(11):8821-8831. 192348, 9343242.
5. Gorodinsky A, Harris DA. Glycolipid-anchored proteins in neuroblastoma cells form detergent-resistant complexes without caveolin. J Cell Biol 1995, 129(3):619-627. 10.1083/jcb.129.3.619, 2120430, 7537273.
6. Christensen HM, Harris DA. Prion protein lacks robust cytoprotective activity in cultured cells. Mol Neurodegener 2008, 3:11. 10.1186/1750-1326-3-11, 2546390, 18718018.
7. Puglielli L, Tanzi RE, Kovacs DM. Alzheimer's disease: the cholesterol connection. Nat Neurosci 2003, 6(4):345-351. 10.1038/nn0403-345, 12658281.
8. De Strooper B, Saftig P, Craessaerts K, Vanderstichele H, Guhde G, Annaert W, Von Figura K, Van Leuven F. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 1998, 391(6665):387-390. 10.1038/34910, 9450754.
9. Tamboli IY, Prager K, Thal DR, Thelen KM, Dewachter I, Pietrzik CU, St George-Hyslop P, Sisodia SS, De Strooper B, Heneka MT, et al. Loss of gamma-secretase function impairs endocytosis of lipoprotein particles and membrane cholesterol homeostasis. J Neurosci 2008, 28(46):12097-12106. 10.1523/JNEUROSCI.2635-08.2008, 19005074.
10. Taraboulos A, Scott M, Semenov A, Avrahami D, Laszlo L, Prusiner SB. Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform. J Cell Biol 1995, 129(1):121-132. 10.1083/jcb.129.1.121, 2120366, 7698979.
11. Haviv Y, Avrahami D, Ovadia H, Ben-Hur T, Gabizon R, Sharon R. Induced neuroprotection independently from PrPSc accumulation in a mouse model for prion disease treated with simvastatin. Arch Neurol 2008, 65(6):762-775. 10.1001/archneur.65.6.762, 18541796.
12. Vetrugno V, Di Bari MA, Nonno R, Puopolo M, D'Agostino C, Pirisinu L, Pocchiari M, Agrimi U. Oral pravastatin prolongs survival time of scrapie-infected mice. J Gen Virol 2009, 90(Pt 7):1775-1780.
13. Mok SW, Thelen KM, Riemer C, Bamme T, Gultner S, Lutjohann D, Baier M. Simvastatin prolongs survival times in prion infections of the central nervous system. Biochem Biophys Res Commun 2006, 348(2):697-702. 10.1016/j.bbrc.2006.07.123, 16890918.
14. Gilch S, Bach C, Lutzny G, Vorberg I, Schatzl HM. Inhibition of cholesterol recycling impairs cellular PrP(Sc) propagation. Cell Mol Life Sci 2009, 66(24):3979-3991. 10.1007/s00018-009-0158-4, 2777232, 19823766.
15. Bach C, Gilch S, Rost R, Greenwood AD, Horsch M, Hajj GN, Brodesser S, Facius A, Schadler S, Sandhoff K, et al. Prion-induced activation of cholesterogenic gene expression by Srebp2 in neuronal cells. J Biol Chem 2009, 284(45):31260-31269. 10.1074/jbc.M109.004382, 2781524, 19748890.
16. Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M, Watts L, Booten SL, Graham M, McKay R, et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 2006, 3(2):87-98. 10.1016/j.cmet.2006.01.005, 16459310.
17. Iliopoulos D, Drosatos K, Hiyama Y, Goldberg IJ, Zannis VI. MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism. J Lipid Res 2010, 51(6):1513-1523. 10.1194/jlr.M004812, 3035515, 20124555.
18. Marquart TJ, Allen RM, Ory DS, Baldan A. miR-33 links SREBP-2 induction to repression of sterol transporters. Proc Natl Acad Sci U S A 2010, 107(27):12228-12232. 10.1073/pnas.1005191107, 2901433, 20566875.
19. Najafi-Shoushtari SH, Kristo F, Li Y, Shioda T, Cohen DE, Gerszten RE, Naar AM. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science (New York, NY) 2010, 328(5985):1566-1569.
20. Rayner KJ, Suarez Y, Davalos A, Parathath S, Fitzgerald ML, Tamehiro N, Fisher EA, Moore KJ, Fernandez-Hernando C. MiR-33 contributes to the regulation of cholesterol homeostasis. Science (New York, NY) 2010, 328(5985):1570-1573.
21. Gatfield D, Le Martelot G, Vejnar CE, Gerlach D, Schaad O, Fleury-Olela F, Ruskeepaa AL, Oresic M, Esau CC, Zdobnov EM, et al. Integration of microRNA miR-122 in hepatic circadian gene expression. Genes Dev 2009, 23(11):1313-1326. 10.1101/gad.1781009, 2701584, 19487572.
22. Bushati N, Cohen SM. microRNA functions. Annu Rev Cell Dev Biol 2007, 23:175-205. 10.1146/annurev.cellbio.23.090506.123406, 17506695.
23. Winter J, Jung S, Keller S, Gregory RI, Diederichs S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 2009, 11(3):228-234. 10.1038/ncb0309-228, 19255566.
24. Kim J, Inoue K, Ishii J, Vanti WB, Voronov SV, Murchison E, Hannon G, Abeliovich A. A MicroRNA feedback circuit in midbrain dopamine neurons. Science (New York, NY) 2007, 317(5842):1220-1224.
25. Packer AN, Xing Y, Harper SQ, Jones L, Davidson BL. The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease. J Neurosci 2008, 28(53):14341-14346. 10.1523/JNEUROSCI.2390-08.2008, 3124002, 19118166.
26. Lukiw WJ. Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus. Neuroreport 2007, 18(3):297-300. 10.1097/WNR.0b013e3280148e8b, 17314675.
27. Saba R, Goodman CD, Huzarewich RL, Robertson C, Booth SA. A miRNA signature of prion induced neurodegeneration. PLoS One 2008, 3(11):e3652. 10.1371/journal.pone.0003652, 2575400, 18987751.
28. Montag J, Hitt R, Opitz L, Schulz-Schaeffer WJ, Hunsmann G, Motzkus D. Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease. Mol Neurodegener 2009, 4:36. 10.1186/1750-1326-4-36, 2743691, 19712440.
29. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005, 433(7027):769-773. 10.1038/nature03315, 15685193.
30. Baek D, Villen J, Shin C, Camargo FD, Gygi SP, Bartel DP. The impact of microRNAs on protein output. Nature 2008, 455(7209):64-71. 10.1038/nature07242, 2745094, 18668037.
31. Bagga S, Bracht J, Hunter S, Massirer K, Holtz J, Eachus R, Pasquinelli AE. Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell 2005, 122(4):553-563. 10.1016/j.cell.2005.07.031, 16122423.
32. Cheng C, Li LM. Inferring microRNA activities by combining gene expression with microRNA target prediction. PLoS One 2008, 3(4):e1989. 10.1371/journal.pone.0001989, 2291556, 18431476.
33. Guo H, Ingolia NT, Weissman JS, Bartel DP. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010, 466(7308):835-840. 10.1038/nature09267, 2990499, 20703300.
34. Nunez-Iglesias J, Liu CC, Morgan TE, Finch CE, Zhou XJ. Joint genome-wide profiling of miRNA and mRNA expression in Alzheimer's disease cortex reveals altered miRNA regulation. PLoS One 2010, 5(2):e8898. 10.1371/journal.pone.0008898, 2813862, 20126538.
35. Tatro ET, Scott ER, Nguyen TB, Salaria S, Banerjee S, Moore DJ, Masliah E, Achim CL, Everall IP. Evidence for Alteration of Gene Regulatory Networks through MicroRNAs of the HIV-infected brain: novel analysis of retrospective cases. PLoS One 2010, 5(4):e10337. 10.1371/journal.pone.0010337, 2859933, 20436668.
36. Enright AJ, John B, Gaul U, Tuschl T, Sander C, Marks DS. MicroRNA targets in Drosophila. Genome Biol 2003, 5(1):R1. 10.1186/gb-2003-5-1-r1, 395733, 14709173.
37. Winer J, Jung CK, Shackel I, Williams PM. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 1999, 270(1):41-49. 10.1006/abio.1999.4085, 10328763.
38. Parameswaran P, Sklan E, Wilkins C, Burgon T, Samuel MA, Lu R, Ansel KM, Heissmeyer V, Einav S, Jackson W, et al. Six RNA viruses and forty-one hosts: viral small RNAs and modulation of small RNA repertoires in vertebrate and invertebrate systems. PLoS Pathog 2010, 6(2):e1000764. 10.1371/journal.ppat.1000764, 2820531, 20169186.
39. Burroughs AM, Ando Y, de Hoon MJ, Tomaru Y, Nishibu T, Ukekawa R, Funakoshi T, Kurokawa T, Suzuki H, Hayashizaki Y, et al. A comprehensive survey of 3' animal miRNA modification events and a possible role for 3' adenylation in modulating miRNA targeting effectiveness. Genome Res 2010, 20(10):1398-1410. 10.1101/gr.106054.110, 2945189, 20719920.
40. Wu H, Ye C, Ramirez D, Manjunath N. Alternative processing of primary microRNA transcripts by Drosha generates 5' end variation of mature microRNA. PLoS One 2009, 4(10):e7566. 10.1371/journal.pone.0007566, 2762519, 19859542.
41. Chiang HR, Schoenfeld LW, Ruby JG, Auyeung VC, Spies N, Baek D, Johnston WK, Russ C, Luo S, Babiarz JE, et al. Mammalian microRNAs: experimental evaluation of novel and previously annotated genes. Genes Dev 2011, 24(10):992-1009.
42. Zhao S, Liu MF. Mechanisms of microRNA-mediated gene regulation. Science in China 2009, 52(12):1111-1116. 10.1007/s11427-009-0152-y, 20016967.
43. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M, et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007, 129(7):1401-1414. 10.1016/j.cell.2007.04.040, 2681231, 17604727.
44. Babak T, Zhang W, Morris Q, Blencowe BJ, Hughes TR. Probing microRNAs with microarrays: tissue specificity and functional inference. RNA 2004, 10(11):1813-1819. 10.1261/rna.7119904, 1370668, 15496526.
45. Mellios N, Huang HS, Grigorenko A, Rogaev E, Akbarian S. A set of differentially expressed miRNAs, including miR-30a-5p, act as post-transcriptional inhibitors of BDNF in prefrontal cortex. Hum Mol Genet 2008, 17(19):3030-3042. 10.1093/hmg/ddn201, 2722882, 18632683.
46. Lee EJ, Baek M, Gusev Y, Brackett DJ, Nuovo GJ, Schmittgen TD. Systematic evaluation of microRNA processing patterns in tissues, cell lines, and tumors. RNA (New York, NY) 2008, 14(1):35-42.
47. Linsen SE, de Wit E, Janssens G, Heater S, Chapman L, Parkin RK, Fritz B, Wyman SK, de Bruijn E, Voest EE, et al. Limitations and possibilities of small RNA digital gene expression profiling. Nat Methods 2009, 6(7):474-476. 10.1038/nmeth0709-474, 19564845.
48. Meyer SU, Pfaffl MW, Ulbrich SE. Normalization strategies for microRNA profiling experiments: a 'normal' way to a hidden layer of complexity?. Biotechnol Lett 2010, 32(12):1777-1788. 10.1007/s10529-010-0380-z, 20703800.
49. Saba R, Gushue S, Huzarewich RL, Manguiat K, Medina S, Robertson C, Booth SA. MicroRNA 146a (miR-146a) is over-expressed during prion disease and modulates the innate immune response and the microglial activation state. PLoS One 2012, 7(2):e30832. 10.1371/journal.pone.0030832, 3281888, 22363497.
50. Lukiw WJ, Dua P, Pogue AI, Eicken C, Hill JM. Upregulation of micro RNA-146a (miRNA-146a), a marker for inflammatory neurodegeneration, in sporadic Creutzfeldt-Jakob disease (sCJD) and Gerstmann-Straussler-Scheinker (GSS) syndrome. J Toxicol Environ Heal 2011, 74(22-24):1460-1468.
51. Majer A, Booth SA. Computational methodologies for studying non-coding RNAs relevant to central nervous system function and dysfunction. Brain Res 2010, 1338:131-145.
52. Sarkar S, Dey BK, Dutta A. MiR-322/424 and -503 are induced during muscle differentiation and promote cell cycle quiescence and differentiation by down-regulation of Cdc25A. Mol Biol Cell 2010, 21(13):2138-2149. 10.1091/mbc.E10-01-0062, 2893979, 20462953.
53. Forrest AR, Kanamori-Katayama M, Tomaru Y, Lassmann T, Ninomiya N, Takahashi Y, de Hoon MJ, Kubosaki A, Kaiho A, Suzuki M, et al. Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation. Leukemia 2010, 24(2):460-466. 10.1038/leu.2009.246, 19956200.
54. Mendell JT. miRiad roles for the miR-17-92 cluster in development and disease. Cell 2008, 133(2):217-222. 10.1016/j.cell.2008.04.001, 2732113, 18423194.
55. Barroso-delJesus A, Romero-Lopez C, Lucena-Aguilar G, Melen GJ, Sanchez L, Ligero G, Berzal-Herranz A, Menendez P. Embryonic stem cell-specific miR302-367 cluster: human gene structure and functional characterization of its core promoter. Mol Cell Biol 2008, 28(21):6609-6619. 10.1128/MCB.00398-08, 2573233, 18725401.
56. Triboulet R, Mari B, Lin YL, Chable-Bessia C, Bennasser Y, Lebrigand K, Cardinaud B, Maurin T, Barbry P, Baillat V, et al. Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science (New York, NY) 2007, 315(5818):1579-1582.
57. Chasseigneaux S, Pastore M, Britton-Davidian J, Manie E, Stern MH, Callebert J, Catalan J, Casanova D, Belondrade M, Provansal M, et al. Genetic heterogeneity versus molecular analysis of prion susceptibility in neuroblasma N2a sublines. Arch Virol 2008, 153(9):1693-1702. 10.1007/s00705-008-0177-8, 18696008.
58. Burns M, Duff K. Cholesterol in Alzheimer's disease and tauopathy. Ann N Y Acad Sci 2002, 977:367-375. 10.1111/j.1749-6632.2002.tb04839.x, 12480774.
59. Valenza M, Rigamonti D, Goffredo D, Zuccato C, Fenu S, Jamot L, Strand A, Tarditi A, Woodman B, Racchi M, et al. Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease. J Neurosci 2005, 25(43):9932-9939. 10.1523/JNEUROSCI.3355-05.2005, 16251441.
60. Valenza M, Cattaneo E. Cholesterol dysfunction in neurodegenerative diseases: is Huntington's disease in the list?. Prog Neurobiol 2006, 80(4):165-176. 10.1016/j.pneurobio.2006.09.005, 17067733.
61. Ohm TG, Treiber-Held S, Distl R, Glockner F, Schonheit B, Tamanai M, Meske V. Cholesterol and tau protein-findings in Alzheimer's and Niemann Pick C's disease. Pharmacopsychiatry 2003, 36(Suppl 2):S120-S126.